133 related articles for article (PubMed ID: 28265335)
1. Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device.
Nerenz RD; Gronowski AM; Grenache DG
West J Emerg Med; 2017 Feb; 18(2):324-325. PubMed ID: 28265335
[No Abstract] [Full Text] [Related]
2. In reply to: “Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device”.
Gottlieb M; Wnek K; Moskoff J; Christian E; Bailitz J
West J Emerg Med; 2017 Feb; 18(2):326. PubMed ID: 29911828
[No Abstract] [Full Text] [Related]
3. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.
Nerenz RD; Gronowski AM
Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957
[No Abstract] [Full Text] [Related]
5. Performance of qualitative urinary hCG assays.
Nickmans S; Vermeersch P; Van Eldere J; Billen J
Acta Clin Belg; 2014 Aug; 69(4):277-9. PubMed ID: 24846178
[TBL] [Abstract][Full Text] [Related]
6. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
[TBL] [Abstract][Full Text] [Related]
7. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the CLINITEST® human chorionic gonadotropin (hCG) pregnancy test for susceptibility to the hook effect by the hCG β core fragment.
Ledden DJ; Novamo AK; Schulman LS
Clin Chem; 2014 Dec; 60(12):1578-80. PubMed ID: 25248572
[No Abstract] [Full Text] [Related]
9. Heterophile antibody interference in qualitative urine/serum hCG devices: Case report.
Patel KK; Gronowski AM
Clin Biochem; 2016 Jun; 49(9):729-731. PubMed ID: 26968106
[TBL] [Abstract][Full Text] [Related]
10. Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.
de Boer D; Houben C; Bekers O; Menheere PP
Clin Biochem; 2010 Nov; 43(16-17):1371-2. PubMed ID: 20727868
[TBL] [Abstract][Full Text] [Related]
11. False-Negative Urine Human Chorionic Gonadotropin Testing in the Clinical Laboratory.
Herskovits AZ; Chen Y; Latifi N; Ta RM; Kriegel G
Lab Med; 2020 Jan; 51(1):86-93. PubMed ID: 31245816
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices.
Kyriacou C; Yang W; Kapur S; Maheetharan S; Pikovsky M; Parker N; Barcroft J; Bobdiwala S; Sur S; Stalder C; Gould D; Ofili-Yebovi D; Day A; Unsworth N; Wilkes EH; Tan T; Bourne T
Clin Chem Lab Med; 2024 Mar; 62(4):664-673. PubMed ID: 37886834
[TBL] [Abstract][Full Text] [Related]
13. The hCG assay or pregnancy test.
Cole LA
Clin Chem Lab Med; 2012 Apr; 50(4):617-30. PubMed ID: 22149742
[TBL] [Abstract][Full Text] [Related]
14. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
15. Analytical sensitivity of four commonly used hCG point of care devices.
Kamer SM; Foley KF; Schmidt RL; Greene DN
Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
[TBL] [Abstract][Full Text] [Related]
16. Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood.
von Lode P; Rainaho J; Pettersson K
Clin Chem; 2004 Jun; 50(6):1026-35. PubMed ID: 15073089
[TBL] [Abstract][Full Text] [Related]
17. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number.
Gronowski AM; Powers M; Stenman UH; Ashby L; Scott MG
Clin Chem; 2009 Oct; 55(10):1885-6. PubMed ID: 19679628
[No Abstract] [Full Text] [Related]
18. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
Johnson S; Eapen S; Smith P; Warren G; Zinaman M
J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
[TBL] [Abstract][Full Text] [Related]
19. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
[TBL] [Abstract][Full Text] [Related]
20. Assessment of biotin interference with qualitative point-of-care hCG test devices.
Williams GR; Cervinski MA; Nerenz RD
Clin Biochem; 2018 Mar; 53():168-170. PubMed ID: 29395091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
